Bhattacharya cancels NIH all-hands meeting

Insurance premiums set to skyrocket if Congress doesn’t reach a deal

With the start of open enrollment less than one week away, millions of Americans are getting their first look at the sharp increases many will pay next year if Congress fails to extend the enhanced premium tax credits that have expanded healthcare access to over 13 million people since 2021.

October 24, 2025

Vol.51 No.39

By Claire Marie Porter

Clinical Regulatory News Trials & Tribulations

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).

October 17, 2025

Vol.51 No.38

By Edison T. Liu

News Analysis Regulatory News

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

Bowing to the growing animal rights movement, FDA and NIH have made policy changes to discourage animal testing, instead favoring alternative research models.

October 17, 2025

Vol.51 No.38

By Claire Marie Porter and Jacquelyn Cobb

Cancer Policy

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

NIH has published a policy that prohibits U.S. researchers and NIH grant recipients working with human biospecimens to share this data with “countries of concern.” That list includes China (including Hong Kong and Macau), Russia, Iran, North Korea, Cuba, and Venezuela.

California enacts regulations on private equity acquisitions of healthcare facilities

Governor Gavin Newsom Oct. 6 signed into law SB 351—a piece of legislation that prohibits hedge fund and private equity groups from interfering with the medical decisionmaking of physicians and their patients.

United for Medical Research report shows NIH funding benefits patients, researchers

United for Medical Research conducted a report surveying patients and researchers on why NIH, and NIH funding matters to them.

October 10, 2025

Vol.51 No.37

By Claire Marie Porter

Bhattacharya cancels NIH all-hands meeting

YOU MAY BE INTERESTED IN

Insurance premiums set to skyrocket if Congress doesn’t reach a deal

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

California enacts regulations on private equity acquisitions of healthcare facilities

United for Medical Research report shows NIH funding benefits patients, researchers

Renew today!

Subscriber content

Never miss an issue!

Login

Bhattacharya cancels NIH all-hands meeting

YOU MAY BE INTERESTED IN

Insurance premiums set to skyrocket if Congress doesn’t reach a deal

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

How animal testing became a MAHA political wedge issueWhile cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

California enacts regulations on private equity acquisitions of healthcare facilities

United for Medical Research report shows NIH funding benefits patients, researchers

Never miss an issue!

Login

How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough